IntelliCell BioSciences, Inc. (SVFC)
-OTC Markets | Prev Close: | 0.09 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.05 - 0.45 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 52,153 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- INTELLICELL BIOSCIENCES, INC. FinancialsEDGAR Online Financials(Wed, Apr 24)
- INTELLICELL BIOSCIENCES, INC. FinancialsEDGAR Online Financials(Wed, Apr 24)
- INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, FinancialEDGAR Online(Wed, Apr 24)
- INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Other EventsEDGAR Online(Wed, Mar 27)
- INTELLICELL BIOSCIENCES, INC. FinancialsEDGAR Online Financials(Sat, May 26)
Reports
- No Reports available for SVFC at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
IntelliCell BioSciences, Inc. operates as a regenerative medicine company. Its proprietary patent pending process involves the application of ultrasonic cavitation (sound waves) to the extracted adipose tissue for the separation of adult autologou...
View More 
0.61%